• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外科医生与放射肿瘤学医生组合对口腔癌治疗结果的影响

Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes.

作者信息

Wihlidal Jacob, Esemezie Alex O, Huang Shao Hui, Watson Erin, Gilbert Ralph W, Waldron John, Gullane Patrick J, Hope Andrew, Irish Jonathan C, O'Sullivan Brian, Chepeha Douglas B, Kim John J H, Brown Dale, Cho B C John, Witterick Ian J, Monteiro Eric, Davies Joel C, Ringash Jolie, Goldstein David P, Bratman Scott, Bayley Andrew, de Almeida John R, Chan Timothy C Y, Hosni Ali, Yao Christopher M K L

机构信息

Department of Otolaryngology - Head and Neck Surgery, University of Toronto, Toronto, ON, Canada.

Department of Otolaryngology - Head and Neck Surgery, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.

出版信息

Ann Surg Oncol. 2025 Feb;32(2):1270-1279. doi: 10.1245/s10434-024-16385-4. Epub 2024 Oct 28.

DOI:10.1245/s10434-024-16385-4
PMID:39467971
Abstract

BACKGROUND

Multidisciplinary care is paramount in patient-specific decision making, especially as pertaining to oral cavity squamous cell cancer (OCSCC) treatment. Protracted surgery-postoperative-radiation (S-PORT) has a detrimental impact on OCSCC patients' outcomes. This study examined the impact of surgeon-radiation oncologist dyads on the treatment of OCSCC, focusing on S-PORT interval and disease specific outcomes.

METHODS

All OCSCC patients treated in a tertiary cancer center between 2009 to 2017 were included. Patients were categorized into "dyad" and "nondyad" groups defined as whether they were treated by a paired surgeon-radiation oncology team with joint multidisciplinary clinic or shared >30% patient volumes. Univariate and multivariate logistic regression were performed to identify factors associated with a prolonged S-PORT time interval (≥8 weeks). Overall survival and locoregional recurrence were estimated and compared.

RESULTS

A total of 444 OCSCC were eligible. Treatment by a dyad was significantly less likely associated with S-PORT ≥ 8 weeks (odds ratio [OR]: 0.65; 95% confidence interval [CI] 0.44-0.96; p = 0.03). Obtaining pre-operative radiation oncology consultation also decreased the S-PORT interval. Advanced T-category and the need for free tissue flap reconstruction increased the likelihood of prolonged S-PORT on univariate but not multivariate analysis. No significant differences were observed in overall survival or locoregional recurrence by dyad status nor S-PORT (p > 0.05).

CONCLUSIONS

Surgeon-radiation oncology dyads significantly minimized time from surgery to postoperative radiation in OCSCC. While improvement in overall survival or locoregional recurrence was not observed, these findings support close knit collaborative multidisciplinary treatment care models, including dyad-based care.

摘要

背景

多学科护理在针对患者的决策制定中至关重要,尤其是在口腔鳞状细胞癌(OCSCC)治疗方面。长期的手术-术后-放疗(S-PORT)对OCSCC患者的预后有不利影响。本研究探讨了外科医生-放疗肿瘤学家二元组对OCSCC治疗的影响,重点关注S-PORT间隔和疾病特异性结局。

方法

纳入2009年至2017年在三级癌症中心接受治疗的所有OCSCC患者。患者被分为“二元组”和“非二元组”,定义为他们是否由配对的外科医生-放疗肿瘤学团队进行治疗,该团队设有联合多学科诊所或共享超过30%的患者量。进行单因素和多因素逻辑回归分析,以确定与延长的S-PORT时间间隔(≥8周)相关的因素。估计并比较总生存期和局部区域复发情况。

结果

共有444例OCSCC患者符合条件。由二元组进行治疗与S-PORT≥8周的相关性显著降低(比值比[OR]:0.65;95%置信区间[CI] 0.44 - 0.96;p = 0.03)。获得术前放疗肿瘤学会诊也缩短了S-PORT间隔。在单因素分析中,晚期T分期和游离组织瓣重建的需求增加了S-PORT延长的可能性,但在多因素分析中并非如此。二元组状态或S-PORT在总生存期或局部区域复发方面未观察到显著差异(p > 0.05)。

结论

外科医生-放疗肿瘤学二元组显著缩短了OCSCC患者从手术到术后放疗的时间。虽然未观察到总生存期或局部区域复发有所改善,但这些发现支持紧密协作的多学科治疗护理模式,包括基于二元组的护理。

相似文献

1
Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes.外科医生与放射肿瘤学医生组合对口腔癌治疗结果的影响
Ann Surg Oncol. 2025 Feb;32(2):1270-1279. doi: 10.1245/s10434-024-16385-4. Epub 2024 Oct 28.
2
Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.口腔鳞状细胞癌术后辅助放疗和挽救性放疗的长期预后
Laryngoscope. 2018 Nov;128(11):2539-2545. doi: 10.1002/lary.27191. Epub 2018 Apr 10.
3
Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.计划性术后放疗前预测口腔鳞状细胞癌早期复发的因素及挽救性强化放疗后的结局。
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):363-373. doi: 10.1016/j.ijrobp.2018.09.013. Epub 2018 Sep 21.
4
Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.手术与辅助治疗之间的时间间隔与口腔癌患者生存的关系。
Otolaryngol Head Neck Surg. 2018 Jun;158(6):1051-1056. doi: 10.1177/0194599817751679. Epub 2018 Jan 9.
5
Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.学术中心口腔癌辅助放疗的疗效改善:配对分析
Laryngoscope. 2014 Jul;124(7):1603-8. doi: 10.1002/lary.24552. Epub 2014 Feb 6.
6
Impact of postoperative radiation therapy for deeply invasive oral cavity cancer upstaged to stage III.术后放疗对深度浸润性口腔癌分期上调至 III 期的影响。
Head Neck. 2019 May;41(5):1178-1183. doi: 10.1002/hed.25498. Epub 2019 Feb 18.
7
Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.淋巴结比率与口腔癌患者复发和生存结局的关系。
JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):53-61. doi: 10.1001/jamaoto.2018.2974.
8
Prognostic significance of preoperative Naples prognostic score for disease-free and overall survival in oral cavity squamous cell carcinoma post-surgery.术前那不勒斯预后评分对口腔鳞状细胞癌术后无病生存期和总生存期的预后意义。
BMC Cancer. 2025 Apr 22;25(1):757. doi: 10.1186/s12885-025-14146-4.
9
Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base.早期口腔癌生存相关的治疗因素:来自国家癌症数据库的 6830 例分析。
JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):593-8. doi: 10.1001/jamaoto.2015.0719.
10
Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma.老年人口腔鳞状细胞癌治疗的临床结局。
Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):775-783. doi: 10.1016/j.ijrobp.2017.03.017. Epub 2017 Mar 18.

引用本文的文献

1
Comment on "Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes".关于“外科医生-放射肿瘤学二元组对口腔癌治疗结果的影响”的评论
Ann Surg Oncol. 2025 Jun 16. doi: 10.1245/s10434-025-17671-5.

本文引用的文献

1
The effect of treatment package time on locally advanced oral cavity cancer outcomes.治疗套餐时间对局部晚期口腔癌结局的影响。
Oral Oncol. 2024 Jul;154:106870. doi: 10.1016/j.oraloncology.2024.106870. Epub 2024 May 31.
2
Predictors of prolonged treatment time intervals in oral cavity cancer.口腔癌治疗时间间隔延长的预测因素。
Oral Oncol. 2023 Dec;147:106622. doi: 10.1016/j.oraloncology.2023.106622. Epub 2023 Nov 8.
3
Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer.口腔癌患者治疗延误的肿瘤学意义。
JAMA Otolaryngol Head Neck Surg. 2023 Nov 1;149(11):961-969. doi: 10.1001/jamaoto.2023.1936.
4
Association Between Familiarity of the Surgeon-Anesthesiologist Dyad and Postoperative Patient Outcomes for Complex Gastrointestinal Cancer Surgery.外科医生-麻醉师双人组合的熟悉程度与复杂胃肠道癌症手术术后患者结局的关系。
JAMA Surg. 2023 May 1;158(5):465-473. doi: 10.1001/jamasurg.2022.8228.
5
Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.头颈部肿瘤外科手术后的加速康复(ERAS):对计划肿瘤治疗回归(RIOT)和生存的影响。
Oral Oncol. 2022 Jul;130:105906. doi: 10.1016/j.oraloncology.2022.105906. Epub 2022 May 17.
6
Survival Associated With Consolidated Multidisciplinary Care in Head and Neck Cancer: A Retrospective Cohort Study.生存与头颈部癌症的综合多学科治疗相关:一项回顾性队列研究。
Otolaryngol Head Neck Surg. 2023 Jan;168(1):82-90. doi: 10.1177/01945998211057852.
7
Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients.质量改进干预措施以减少头颈部游离皮瓣患者术后放疗的时间。
Head Neck. 2021 Nov;43(11):3530-3539. doi: 10.1002/hed.26852. Epub 2021 Sep 7.
8
Impact of delay in diagnosis and treatment-initiation on disease stage and survival in oral cavity cancer: a systematic review.诊断和治疗启动延迟对口腔癌疾病分期和生存的影响:系统评价。
Acta Oncol. 2021 Sep;60(9):1083-1090. doi: 10.1080/0284186X.2021.1931712. Epub 2021 May 27.
9
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.基于导航的多层次干预措施的制定和评估,以改善头颈部癌症患者及时给予符合指南的辅助治疗。
JCO Oncol Pract. 2021 Oct;17(10):e1512-e1523. doi: 10.1200/OP.20.00943. Epub 2021 Mar 10.
10
Treatment delay in early-stage oral squamous cell carcinoma and its relation to survival.早期口腔鳞状细胞癌的治疗延误及其与生存的关系。
J Craniomaxillofac Surg. 2021 Jun;49(6):462-467. doi: 10.1016/j.jcms.2021.02.007. Epub 2021 Feb 12.